site stats

Reshape medical stock

WebAug 15, 2024 · Second Quarter Ended June 30, 2024 Financial and Operating Results. Revenue totaled $2.9 million for the three months ended June 30, 2024, which represents a contraction of 18.1%, or $0.6 million ... WebReShape Medical General Information. Description. Developer of an integrated gastric dual balloon system designed to transform weight loss. The company's dual balloon system is …

ReShape Lifesciences Announces 1-for-50 Reverse Stock RSLS …

WebApr 11, 2024 · Trading volume for Reshape Lifesciences's stock is 2.3 million as of 13:30 EST. This is 371.7% of its average full-day volume over the last 100 days. The company's … WebApr 11, 2024 · ReShape Lifesciences (NASDAQ:RSLS) has received a notice of allowance from the U.S. patent office for a patent application related to its Obalon balloon system.The patent will cover additional ... fwc early teal season https://new-lavie.com

Head to Head Review: ReShape Lifesciences (OTCMKTS:RSLS) …

WebApr 11, 2024 · ReShape Lifesciences has a beta of -0.05, suggesting that its stock price is 105% less volatile than the S&P 500. ... ReShape Lifesciences, Inc. is a medical device company, ... WebFind the latest ReShape Lifesciences Inc. (RSLS) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest ReShape Lifesciences Inc. (RSLS) stock discussion in Yahoo … Discover historical prices for RSLS stock on Yahoo Finance. View daily, weekly or … Find out the direct holders, institutional holders and mutual fund holders for … Description. ReShape Lifesciences Inc., a medical device company, provides … See ReShape Lifesciences Inc. (RSLS) stock analyst estimates, including earnings and … See ReShape Lifesciences Inc. (RSLS) Environment, Social and Governance … Find the latest ReShape Lifesciences Inc. (RSLS) stock quote, history, news and … Find out all the key statistics for ReShape Lifesciences Inc. (RSLS), including … WebApr 11, 2024 · April 11, 2024 - 8:30 am. SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for … fwce nmsu

12 Health Care Stocks Moving In Thursday

Category:ReShape Medical, Inc. Completes $38 Million Series D Financing

Tags:Reshape medical stock

Reshape medical stock

EnteroMedics Announces Acquisition Of ReShape Medical

WebDec 22, 2024 · SAN CLEMENTE, Calif., Dec. 22, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that ... WebApr 13, 2024 · Summary. OrthoPediatrics beats ReShape Lifesciences on 13 of the 13 factors compared between the two stocks. About ReShape Lifesciences (ReShape …

Reshape medical stock

Did you know?

WebApr 13, 2024 · Summary. OrthoPediatrics beats ReShape Lifesciences on 13 of the 13 factors compared between the two stocks. About ReShape Lifesciences (ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. WebAug 26, 2015 · SAN CLEMENTE, Calif., August 26, 2015 – ReShape Medical ® today announced that it has completed a Series D financing of $38 million led by HealthCor Partners Management, L.P. with participation from Endeavour Vision SA and existing investors, SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners and Venture …

WebMar 7, 2024 · SAN CLEMENTE, Calif., March 7, 2024 /PRNewswire/ -- ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today ...

WebFeb 6, 2024 · ReShape Lifesciences (NASDAQ: RSLS) stock is falling hard on Monday as the company’s shares pull back from a rally on Friday. RSLS stock saw a massive gain on … WebApr 11, 2024 · Trading volume for Reshape Lifesciences's stock is 2.3 million as of 13:30 EST. This is 371.7% of its average full-day volume over the last 100 days. The company's market cap stands at $6.5 million.

WebMedical. Medical Instruments Manufacturing. $0.002B. $0.014B. ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and …

WebFeb 6, 2024 · ReShape Lifesciences Inc Stock Price History. ReShape Lifesciences Inc’s price is currently down 5.52% so far this month. During the month of February, ReShape … fwc english papersWebOct 3, 2024 · Under the terms of the agreement, the consideration paid by EnteroMedics for ReShape Medical consists of 2,356,729 shares of common stock, 187,772 shares of … fwc e-learningWebDec 22, 2024 · SAN CLEMENTE, Calif., Dec. 22, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic … gladys renee metcalfWebReShape Lifesciences ® is committed to the delivery of safe, effective, and sustainable therapies that address the growing global health crises associated with the increased … gladys retreat circleWebApr 12, 2024 · Company Profile RSLS. Business Description. Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. … gladys recardWebOct 3, 2024 · EnteroMedics Inc. (NasdaqCM:ETRM) acquired ReShape Medical Inc. from Endeavour Vision SA and HealthCor Partners Fund II LP managed by HealthCor Partners … fwc e-learning siteWebNov 14, 2024 · ReShape Lifesciences Inc. SAN CLEMENTE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led … gladys reynolds obituary